Remember meForgot password?
    Log in with Twitter

adenovirus News

Chimerix to provide vital drug to Josh Hardy Special

Fredericksburg - Chimerix has announced that it has reached agreement with the U.S. FDA for the initiation of a pilot trial of open-label brincidofovir for the treatment of adenovirus infections in immunocompromised patients. This study is will begin with Josh Hardy.

Op-Ed: Drug company responds to Josh Hardy's case with a 'no' Special

Josh Hardy is a seven-year-old boy and is currently fighting for his life due to a viral disease. There is one drug that could cure him, but the drug company behind it has said that it cannot release it.

Search Digital Journal Archives

Set up a news alert for


adenovirus Image

Latest News
Top News